Zenith Drugs Limited IPO

Zenith Drugs Limited is listed in the SME segment with a price band of ₹75 to ₹79. The figures below are as reported by the exchanges and public sources.

Zenith Drugs Limited IPO — key facts

• The Zenith Drugs Limited IPO price band is ₹75 to ₹79 per share.
• As of 5 September 2026, the Zenith Drugs Limited IPO subscription status is 179.18x overall.
• The issue is open from 19-FEB-2024 to 22-FEB-2024.
• Zenith Drugs Limited listed on 27-FEB-2024.
• Zenith Drugs Limited listed at ₹105.15. The listing gain was 33.1% against the upper end of the issue price band.

Zenith Drugs Limited IPO details

Status

Listed

Segment

SME

Sector

Pharmaceuticals

Price band

₹75 – ₹79

Issue size

₹40.68 Cr

Fresh issue

₹33.94 Cr

Opens

19-FEB-2024

Closes

22-FEB-2024

Listing

27-FEB-2024

Total subscription

179.18x

Retail

139.28x

QIB

106.72x

NII

368.77x

Lead managers

Gretex Corporate

Listing price

₹105.15

Listing day change

+33.1%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.